For example, SOX2, OCT4, and NANOG were found to be overexpressed in several cancers, including breast, prostate, and oral squamous cell carcinoma, and their expression levels were associated with tumor transformation, tumourigenicity, and tumor metastasis (37–39). Here, SOX2 is linked to oral cavity squamous cell carcinoma.